Compositions and methods for diagnosis and treatment of orthopoxviruses

Details for Australian Patent Application No. 2005255019 (hide)

Owner Oregon Health and Science University

Inventors Hammarlund, Erika; Yoshihara, Paul; Slifka, Mark

Agent Davies Collison Cave

Pub. Number AU-B-2005255019

PCT Pub. Number WO2005/123966

Priority 60/579,048 12.06.04 US

Filing date 13 June 2005

Wipo publication date 29 December 2005

Acceptance publication date 19 May 2011

International Classifications

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

A61K 39/275 (2006.01) Medicinal preparations containing antigens or antibodies - Poxviridae, e.g. avipoxvirus

A61K 39/42 (2006.01) Medicinal preparations containing antigens or antibodies - viral

C07K 16/08 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from viruses

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2005/123966 Priority application(s): WO2005/123966

19 May 2011 Application Accepted

  Published as AU-B-2005255019

15 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005255021-Method and apparatus for carrying out a metallurgical process

2005255013-Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia